Astellas Pharma Inc 2022 IR
The report outlines Astellas' progress under its Corporate Strategic Plan 2021 (CSP2021) to realize its vision of turning innovative science into value for patients. Key achievements include a 19% year-on-year increase in sales of XTANDI and strategic products, the submission of a New Drug Application for fezolinetant in the US, and the commercialization of the AI-based MYHOLTER II ECG analysis service. Additionally, the company updated its Materiality Matrix to prioritize nine material issues, including Access to Health and environmental sustainability. Astellas also advanced its organizational health goals by implementing leadership training for approximately 3,000 leaders and introducing shared objectives to foster cross-functional collaboration.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2022
Type: IR
Pages: 92
Back to company
Astellas Pharma Inc
Integrated Report
The report outlines Astellas' progress under its Corporate Strategic Plan 2021 (CSP2021) to realize its vision of turning innovative science into value for patients. Key achievements include a 19% year-on-year increase in sales of XTANDI and strategic products, the submission of a New Drug Application for fezolinetant in the US, and the commercialization of the AI-based MYHOLTER II ECG analysis service. Additionally, the company updated its Materiality Matrix to prioritize nine material issues, including Access to Health and environmental sustainability. Astellas also advanced its organizational health goals by implementing leadership training for approximately 3,000 leaders and introducing shared objectives to foster cross-functional collaboration.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees